SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

EuroPCR 2026 | Could clopidogrel replace aspirin as monotherapy after PCI?

Dr. Andrés Rodríguez - 21 May, 2026 0

This presentation, delivered during EuroPCR 2026, analyzed the clinical outcomes of clopidogrel monotherapy versus aspirin in patients who remained event-free for 12 months after...

EuroPCR 2026 | Are bioresorbable stents making a comeback? Five-year results of FUTURE-II with Firesorb

Dr. Juan Manuel Pérez - 21 May, 2026 0

The first bioresorbable coronary scaffolds generated great expectations because of their potential to restore vascular physiology after device resorption. However, early studies such as...

EuroPCR 2026 | Coronary bioadaptor: fewer events regardless of IVUS or FFR guidance

Dr. Juan Manuel Pérez - 21 May, 2026 0

Despite the increasing use of intracoronary imaging and physiology, stent-related events continue to occur at an annual rate of approximately 2–3% beyond the first...

Noticias Institucionales

SOLACI to Participate in EuroPCR 2026 with a Scientific Session Focused on the Management of Complex Coronary Lesions

solaci - 20 May, 2026 0

The Latin American Society of Interventional Cardiology will have a prominent participation at EuroPCR 2026 through an institutional scientific session bringing together renowned international...

Relive SOLACI’s participation in the V International Congress of Clinical and Interventional Cardiology in the Dominican Republic

solaci - 20 May, 2026 0

The Latin American Society of Interventional Cardiology actively participated in the “V International Congress of Clinical and Interventional Cardiology”, organized by the Asociación Dominicana...

The Preliminary Scientific Program for SOLACI & SBHCI 2026 Is Now Available

solaci - 19 May, 2026 0

The SOLACI & SBHCI 2026 Congress is already beginning to take shape with the official release of its Preliminary Scientific Program — a high-impact...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: EuroPCR 2026

EuroPCR 2026 | Could clopidogrel replace aspirin as monotherapy after PCI?

Últimas Noticias

EuroPCR 2026 | Could clopidogrel replace aspirin as monotherapy after PCI?

EuroPCR 2026 | Are bioresorbable stents making a comeback? Five-year results of FUTURE-II with Firesorb

EuroPCR 2026 | Coronary bioadaptor: fewer events regardless of IVUS or FFR guidance

Noticias Institucionales

SOLACI to Participate in EuroPCR 2026 with a Scientific Session Focused on the Management of Complex Coronary Lesions

Relive SOLACI’s participation in the V International Congress of Clinical and Interventional Cardiology in the Dominican Republic

The Preliminary Scientific Program for SOLACI & SBHCI 2026 Is Now Available

Accesos